SGER: GFP-Based Imaging for Cryobiological Research: A Cryosurgical Application
SGER:用于冷冻生物学研究的基于 GFP 的成像:冷冻外科应用
基本信息
- 批准号:9816734
- 负责人:
- 金额:$ 8.42万
- 依托单位:
- 依托单位国家:美国
- 项目类别:Standard Grant
- 财政年份:1999
- 资助国家:美国
- 起止时间:1999-03-01 至 2001-02-28
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
9816734McGrathThe short-term objective of the research is to demonstrate that a recently developed class of fluorescent molecular probes can be used as in situ tissue viability probes. Specifically, green fluorescent protein (GFP) fluorescent probes developed by molecular biologists will be used in conjunction with an animal skin flap window chamber to allow continuous, dynamic, three-dimensional, in vivo tissue/tumor observations and measurements of fluorescence related to cellular viability. It is expected that the successful demonstration of the feasibility of this approach would allow for exciting and novel subsequent research that would provide an unprecedented level of detail regarding freeze/thaw damage at the cellular and tissue level. It is anticipated that the method will be especially productive when applied to issues related to vasculature injury, which are precisely the issues which state-of-the art research defines as one of the most important to address at this time. Successful completion of this exploratory research is also expected to lead to an improved understanding of the another major shortcoming in our current knowledge: the mechanisms of freeze/thaw injury at "slow" freezing rates for isolated cells as well as for tissues in vitro and in vivo. Finally, future developments of the method using GFPs and transfected immunologically-significant cells could lead to an improved understanding of certain aspects of cell-mediated cryoimmune responses, another important issue in cryosurgery and tissue freezing in general.The long term goal of the research is aimed at developing cryosurgical devices and procedures which would make cryosurgery a cost effective, minimally invasive method for selectively killing tumors while avoiding injury to surrounding normal tissues and to do so for as many cancers as possible. The current state of the art limits the optimization of existing cryosurgical devices and processes as well as the development of new devices and procedures that could extend the use of cryosurgery to other applications. The limiting factor is that the mechanisms by which the freezing and thawing kill the cancerous tissue is not understood well enough. Part of the reason that these mechanisms remain unknown is related to the relatively crude means currently used for assessing viability in tissues in vivo. This research grant will support a woman mechanical engineering graduate student who is conducting research on this topic for her Ph.D. thesis. She intends to pursue an academic career in the field of biomedical engineering. The research has already attracted two female undergraduate engineering students who are beginning to get involved with it and who have expressed interest to pursue graduate study as a part of the research group as a result.
9816734 McGrath该研究的短期目标是证明最近开发的一类荧光分子探针可用作原位组织活力探针。 具体而言,分子生物学家开发的绿色荧光蛋白(GFP)荧光探针将与动物皮瓣窗口室结合使用,以允许连续、动态、三维、体内组织/肿瘤观察和与细胞活力相关的荧光测量。 预计这种方法的可行性的成功证明将允许令人兴奋的和新颖的后续研究,这将提供前所未有的细节水平,在细胞和组织水平的冻/融损伤。 预计该方法在应用于与脉管系统损伤相关的问题时将特别有效,这些问题正是最先进的研究定义为此时要解决的最重要的问题之一。 这项探索性研究的成功完成,也有望导致我们目前的知识的另一个主要缺点:冷冻/解冻损伤的机制,在“慢”冷冻速率分离的细胞,以及在体外和体内的组织的更好的理解。 最后,使用GFP和转染的免疫显著细胞的方法的未来发展可能会导致对细胞介导的冷冻免疫应答的某些方面的更好理解,这是冷冻外科和组织冷冻中的另一个重要问题。研究的长期目标是开发冷冻外科设备和程序,使冷冻外科具有成本效益,选择性杀死肿瘤的微创方法,同时避免损伤周围正常组织,并尽可能多地治疗癌症。 现有技术的现状限制了现有冷冻外科装置和过程的优化以及可以将冷冻外科的使用扩展到其他应用的新装置和过程的开发。 限制因素是冷冻和解冻杀死癌组织的机制还不够清楚。 这些机制仍然未知的部分原因与目前用于评估体内组织活力的相对粗糙的方法有关。这项研究补助金将支持一名机械工程女研究生,她正在为博士学位进行这一主题的研究。论文 她打算在生物医学工程领域从事学术事业。 这项研究已经吸引了两名工程系女本科生,她们开始参与这项研究,并表示有兴趣作为研究小组的一员攻读研究生。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
John McGrath其他文献
A new heterozygous frameshift variant in keratin 10 resulting in ichthyosis hystrix in a father and daughter
- DOI:
10.1016/j.jdcr.2023.02.015 - 发表时间:
2023-05-01 - 期刊:
- 影响因子:
- 作者:
Lauren Kerry Knight;John McGrath;Linda Ozoemena;Riyaadh Roberts;Carol Hlela - 通讯作者:
Carol Hlela
Recruitment aids for a phase II randomised trial in low risk bladder cancer
- DOI:
10.1016/j.ejso.2016.07.104 - 发表时间:
2016-11-01 - 期刊:
- 影响因子:
- 作者:
Rebecca Lewis;Lauren Maynard;James Catto;Joanne Cresswell;Andrew Feber;T.R. Leyshon Griffiths;John Kelly;Allen Knight;Maggie Knowles;John McGrath;Steven Penegar;Emma Hall;Hugh Mostafid; CALIBER Trial Management Group - 通讯作者:
CALIBER Trial Management Group
PD66-04 RESULTS OF CALIBER: A PHASE II RANDOMISED FEASIBILITY TRIAL OF CHEMOABLATION VERSUS SURGICAL MANAGEMENT IN LOW RISK NON-MUSCLE INVASIVE BLADDER CANCER (NMIBC)
- DOI:
10.1016/j.juro.2018.02.3000 - 发表时间:
2018-04-01 - 期刊:
- 影响因子:
- 作者:
Hugh Mostafid;Joanne Cresswell;Leyshon Griffiths;John Kelly;Allen Knight;James Catto;Kim Davenport;Andrew Feber;Margaret Knowles;John McGrath;Peter Cooke;Shikohe Masood;Aicha Goubar;Steven Penegar;Nuria Porta;Laura Wiley;Rebecca Lewis;Emma Hall - 通讯作者:
Emma Hall
Correction to: Meeting abstracts from the 4th International Clinical Trials Methodology Conference (ICTMC) and the 38th Annual Meeting of the Society for Clinical Trials
- DOI:
10.1186/s13063-017-2392-7 - 发表时间:
2018-02-09 - 期刊:
- 影响因子:2.000
- 作者:
Steven Penegar;Rebecca Lewis;James Catto;Joanne Cresswell;Leyshon Griffiths;Micki Hill;John Kelly;Allen Knight;John McGrath;Laura Wiley;Hugh Mostafid;Emma Hall - 通讯作者:
Emma Hall
The Return to Craft: Taylor Swift, Nostalgia, and Covid-19
回归手工艺:泰勒·斯威夫特、怀旧和 Covid-19
- DOI:
10.1080/03007766.2022.2156761 - 发表时间:
2022 - 期刊:
- 影响因子:0.5
- 作者:
John McGrath - 通讯作者:
John McGrath
John McGrath的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('John McGrath', 18)}}的其他基金
Micro-Scale, Multi-Spectral Flourescent Imaging for Bio-Heat Transfer Applications
用于生物传热应用的微尺度、多光谱荧光成像
- 批准号:
0101161 - 财政年份:2001
- 资助金额:
$ 8.42万 - 项目类别:
Standard Grant
Coordinated Experimental and Numerical Studies of AutomotiveMultiphase Convective Transport Phenomena: A Ford Motor Company-Michigan State University Collaboration
汽车多相对流传输现象的协调实验和数值研究:福特汽车公司与密歇根州立大学的合作
- 批准号:
9710956 - 财政年份:1997
- 资助金额:
$ 8.42万 - 项目类别:
Standard Grant
Group International Travel Grant to Attend Workshop in Frankfort, Germany, May 1994.
团体国际旅行补助金参加 1994 年 5 月在德国法兰克福举行的研讨会。
- 批准号:
9224386 - 财政年份:1994
- 资助金额:
$ 8.42万 - 项目类别:
Standard Grant
International Group Travel Grant: German Summer Program for Undergraduate Students in Separations, Interfacial, and Transport Phenomena (June - August 1993)
国际团体旅行补助金:德国本科生夏季项目,研究分离、界面和运输现象(1993 年 6 月至 8 月)
- 批准号:
9224387 - 财政年份:1992
- 资助金额:
$ 8.42万 - 项目类别:
Standard Grant
Proposal to Support Faculty Foreign Travel to Germany, Summer 1991
支持教师前往德国出国旅行的提案,1991 年夏季
- 批准号:
9116962 - 财政年份:1991
- 资助金额:
$ 8.42万 - 项目类别:
Standard Grant
A Model International Engineering Exchange Program: MSU/RWTH-Aachen, and Kaiserslautern
国际工程交流项目典范:MSU/RWTH-Aachen 和凯泽斯劳滕
- 批准号:
9016477 - 财政年份:1991
- 资助金额:
$ 8.42万 - 项目类别:
Continuing Grant
相似国自然基金
研发一种基于细菌表面展示组氨酸修饰化
GFP 蛋白实现同步检测和修复水中铜离子的
技术
- 批准号:TGS24C010004
- 批准年份:2024
- 资助金额:0.0 万元
- 项目类别:省市级项目
基于Split-GFP技术的生血内皮精确标记和内皮-造血转换机制研究
- 批准号:32301261
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
基于MERVL::tdTomato/OCT4-GFP双荧光报告基因系统鉴定与研究“全能样”干细胞进入与退出的转录调控因子
- 批准号:
- 批准年份:2022
- 资助金额:30 万元
- 项目类别:青年科学基金项目
GFP基因修饰的UC-MSCs对小鼠脑缺血性再灌注炎性反应的调节作用及机制研究
- 批准号:
- 批准年份:2020
- 资助金额:0.0 万元
- 项目类别:省市级项目
GFP发色团类荧光探针的构建及其对视网膜Aβ寡聚体的成像研究
- 批准号:
- 批准年份:2019
- 资助金额:10.0 万元
- 项目类别:省市级项目
利用GFP标记的大丽轮枝菌结合蛋白组测序揭示马铃薯抗黄萎病的分子机制
- 批准号:31860495
- 批准年份:2018
- 资助金额:42.0 万元
- 项目类别:地区科学基金项目
利用GBP-GFP高亲和系统解析裂殖酵母monopolin复合体的多重功能
- 批准号:31671411
- 批准年份:2016
- 资助金额:62.0 万元
- 项目类别:面上项目
利用CRISPR-Cas9系统构建Oct4gfp基因敲入猴模型
- 批准号:81671516
- 批准年份:2016
- 资助金额:85.0 万元
- 项目类别:面上项目
基于Split-GFP技术的幽门螺杆菌IV型分泌系统效应蛋白鉴定及转运识别机制研究
- 批准号:81501718
- 批准年份:2015
- 资助金额:18.0 万元
- 项目类别:青年科学基金项目
流体切应力诱导GFP基因小鼠血管内皮细胞定向分化治疗角膜内皮损伤的机制研究
- 批准号:81560158
- 批准年份:2015
- 资助金额:37.0 万元
- 项目类别:地区科学基金项目
相似海外基金
External GFP fusion enables FRET based binding for addiction related receptors
外部 GFP 融合使得基于 FRET 的成瘾相关受体结合成为可能
- 批准号:
9044181 - 财政年份:2015
- 资助金额:
$ 8.42万 - 项目类别:
Two-photon probes based on GFP-chromophores for biological imaging
用于生物成像的基于 GFP 发色团的双光子探针
- 批准号:
466807-2014 - 财政年份:2014
- 资助金额:
$ 8.42万 - 项目类别:
University Undergraduate Student Research Awards
Novel Split GFP Based Intersynaptic Markers to Study Synaptic Specificity in vivo
基于新型分裂 GFP 的突触间标记用于研究体内突触特异性
- 批准号:
7486600 - 财政年份:2008
- 资助金额:
$ 8.42万 - 项目类别:
A GFP-based HTS Assay for HIV-1 Reactivating Agents
基于 GFP 的 HIV-1 重新激活剂 HTS 测定
- 批准号:
6947524 - 财政年份:2005
- 资助金额:
$ 8.42万 - 项目类别:
A GFP-based HTS Assay for HIV-1 Reactivating Agents
基于 GFP 的 HIV-1 重新激活剂 HTS 测定
- 批准号:
7035316 - 财政年份:2005
- 资助金额:
$ 8.42万 - 项目类别:
GFP-Based Assays to Probe Transcriptional Controls(RMI)
基于 GFP 的转录控制检测 (RMI)
- 批准号:
7021190 - 财政年份:2005
- 资助金额:
$ 8.42万 - 项目类别:
A GFP-based HTS Assay for HIV-1 Reactivating Agents
基于 GFP 的 HIV-1 重新激活剂 HTS 测定
- 批准号:
7225977 - 财政年份:2005
- 资助金额:
$ 8.42万 - 项目类别:
A GFP Based HTS Assay for HIV-1 Tat Inhibitors (RMI)
基于 GFP 的 HIV-1 Tat 抑制剂 (RMI) HTS 测定
- 批准号:
6879840 - 财政年份:2004
- 资助金额:
$ 8.42万 - 项目类别:
Enhance Heterologous Protein Production in High-Density Plant Suspension Cultures using Cell-Cycle Engineering and GFP-based On-line Optimization
使用细胞周期工程和基于 GFP 的在线优化增强高密度植物悬浮培养中的异源蛋白产量
- 批准号:
0126191 - 财政年份:2002
- 资助金额:
$ 8.42万 - 项目类别:
Continuing Grant
Confocal Microscope for Mutant-GFP-Based FRET
用于基于突变 GFP 的 FRET 的共焦显微镜
- 批准号:
6440962 - 财政年份:2002
- 资助金额:
$ 8.42万 - 项目类别: